
Фармсинтез LIFE
Фармсинтез Depreciation And Amortization 2007-2025 | LIFE
Annual Depreciation And Amortization Фармсинтез
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.5 M | 32 M | 44.4 M | 25.9 M | 54.6 M | 42.6 M | 71.9 M | 31.7 M | 36.2 M | 22.9 M | 27.3 M | 28 M | -13.6 M | -7.13 M | -13.7 M | -7.46 M |
All numbers in RUB currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 71.9 M | -13.7 M | 25.2 M |
Quarterly Depreciation And Amortization Фармсинтез
| 2023-Q2 | 2022-Q4 | 2022-Q2 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2011-Q4 | 2011-Q2 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.23 M | 8.18 M | 11.7 M | 15.9 M | 16 M | 26.3 M | 18.1 M | 419 K | 25.5 M | 27 M | 27.6 M | 21.7 M | 29 M | 34.1 M | 37.8 M | 15.5 M | 16.2 M | 18.1 M | 18.1 M | 20.8 M | 6.76 M | 13.7 M | 14 M | 14 M | -6.82 M | -6.82 M | -3.56 M | -3.56 M | -6.85 M | -6.85 M |
All numbers in RUB currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 37.8 M | -6.85 M | 13.7 M |